Tag: Neurodegenerative diseases

news-04082024-230958

Uncovering the Reality of Novel Alzheimer’s Medications

In early July, the US Food and Drug Administration (FDA) approved a new treatment called donanemab for individuals with early-stage Alzheimer’s disease. This medication is the second drug that has been proven to slow...
news-04082024-230808

Advancements in Alzheimer’s Diagnosis: Are Doctors Prepared for New Blood Tests?

A new generation of blood tests is revolutionizing the diagnosis and treatment of Alzheimer's disease, according to doctors. These tests provide a quick and easy way for physicians to determine if a patient experiencing...
news-04082024-225407

Improving Alzheimer’s Blood Tests for Diagnosis: Progress and Challenges

Alzheimer’s disease can be difficult to diagnose, but recent research suggests that proteins in the blood could offer a solution. At the annual Alzheimer’s Association International Conference in Philadelphia, new findings were presented, indicating...